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Summary
A panel of four separate monoclonal antibodies, all
known to specifically recognize epitopes on keratan
sulfate glycosaminoglycans, were employed in an immu-
nocytochemical study of developing chick hind limbs. In
addition, two monoclonal antibodies specific for epitopes
on chondroitin/dermatan sulfate glycosaminoglycans
were employed on equivalent sections to determine the
degree of colocalization of keratan and chondroitin/
dermatan sulfates. The spatial distributions of keratan
sulfate and chondroitin/dermatan sulfate differed to
some extent. In younger embryos, high extracellular
concentrations of keratan sulfate occurred in joints and
articular cartilages, with diminishing amounts being
present in epiphyseal and diaphyseal regions. The high
concentration of keratan sulfate in joints and articular
cartilage corresponded to equally high concentration of
chondroitin-6 sulfate. With advancing age, the above
mentioned distribution was modified, most notably by
increased amounts of keratan sulfate within diaphyseal
regions. Finally, the use of four different anti-keratan
sulfate monoclonal antibodies made it possible to com-
pare keratan sulfate epitope expression. Differences in
keratan sulfate epitopes were noted in some regions of
bones, mostly in diaphyseal regions of younger bones
and epiphyseal regions of older bones. This pattern of
keratan sulfate expression suggests that different types
of keratan sulfate may be present and their expression
may be developmentally regulated.
Key words: keratan sulfate, chondroitin sulfate,
immunocytochemistry, limb development.
Introduction
Keratan sulfate is a glycosaminoglycan that has been
identified as a matrix component of two types of
connective tissues, corneal stroma and cartilage matrix
(Hascall & Hascall, 1981; Hassell et al. 1986). These
keratan sulfates are substituted to core proteins that
may, particularly in cartilage, also be substituted with
chondroitin sulfates (Hassell et al. 1986). More re-
cently, the application of immunochemical and immu-
nocytochemical methods has resulted in the identifi-
cation of keratan sulfate in a much wider variety of
tissues (Hyldahl et al. 1986; Funderburgh et al. 1987;
Sorrell et al. 1988b,c). Furthermore, use of anti-keratan
sulfate monoclonal antibodies has revealed differences
in epitope expression among keratan sulfates (Caterson
et al. 1986; SundarRaj et al. 1986; Funderburgh et al.
1987, 1988). Developmental studies, in which more
than one anti-keratan sulfate monoclonal antibody was
used, have demonstrated both age- and tissue-specific
differences in keratan sulfates. SundarRaj et al. (1986)
have shown that keratan sulfate epitopes appear in a
developmentally defined manner in the rabbit eye.
Funderburgh et al. (1988) found that keratan sulfates in
scar tissue from corneal wounds contained a structurally
different form of keratan sulfate than that found in
normal cornea. Differences in epitopes may be related
to variations in sulfation patterns within glycosamino-
glycans (Mehmet et al. 1986; Tang et al. 1986).
In the present study, four separate anti-keratan
sulfate monoclonal antibodies were used to immuno-
cytochemically identify keratan sulfate in developing
chick hind limbs. These antibodies were used, not only
to identify keratan sulfate, but to determine whether
there were spatial-, age-, or epitope-specific differ-
ences. Keratan sulfate was identified as early as day 5-5
of incubation. At that age, it was largely confined to
joints and articular cartilages, with lesser amounts in
epiphyseal cartilages. These results correspond to the
identification of keratan sulfates in tendon, ligament,
and other noncartilaginous components of joints (Craig
et al. 1987b; Vogel & Evanko, 1987; Daniel & Mills,
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1988). With advancing age, this distribution of keratan
sulfate gradually changed. Extracellular keratan sulfate
now appeared in central regions of bones.
The four anti-keratan sulfate monoclonal antibodies
differed in their ability to detect keratan sulfate in some
regions of developing bones. This was particularly
evident in the intracytoplasmically identified keratan
sulfate of younger bones. However, differential keratan
sulfate epitope expression continued to be present in
cartilage of older bones. Thus, this study indicates that
keratan sulfate is an early component of developing
chick bones and that its expression, like that of chon-
droitin sulfates (Kimata et al. 1974; Stocum et al. 1979;
Shinomura et al. 1984), appears to be developmental^
regulated.

























All four antibodies were raised against purified cartilage
proteoglycan obtained from the sources indicated. Their epitope
specificities were compared in a competitive radioimmunoassay
using corneal keratan sulfate type I (KSI) and skeletal keratan
sulfate type II (KSII) as competing (non-labelled) antigen.
Materials and methods
Antibodies
All four anti-KS monoclonal antibodies, 5D4, 1B4, 2D3, and
4A1, used in this study were raised against purified mam-
malian cartilage proteoglycans. The four anti-keratan sulfate
antibodies were characterized using a competitive radioimmu-
noassay in which 125I-bovine nasal cartilage-ABC-core was
the labelled antigen and keratan sulfate type I (Sigma) and
keratan sulfate type II (Martin & Mathews NIH standard)
were the unlabelled antigens (Caterson et al. 1983). The data
were expressed as nanograms of unlabelled antigen required
to give a 50 % inhibition.
The two monoclonal, anti-chondroitin/dermatan sulfate
antibodies, 2B6 and 3B3, were raised against chondroitinase
ABC-digested cartilage proteoglycans. These antibodies
recognized chondroitin-4- and dermatan sulfates and chon-
droitin-6-sulfate, respectively (Caterson et al. 1985, 1986).
Tissue preparation and immunocytochemistry
Tissues were taken from outbred lines of White Leghorn chick
embryos at the ages indicated in the results section. At earlier
stages, three embryos were used at each time point; two each
were used for later stages. Tissue processing and indirect
immunoperoxidase immunocytochemistry were performed as
previously published (Sorrell et al. 1988a). None of the
immunostained samples that are present in the text were
counterstained. However, other samples were counterstained
with hematoxylin to facilitate localization of intracellular
epitopes.
Controls
Separate controls were performed for each antibody and each
tissue. These included sections in which the primary antibody
incubation step was omitted and sections in which the primary
antibody incubation was performed, but in the presence of
lmgrnP' of purified corneal keratan sulfate (type I). No
immunostain was detected in either situation.
Results
The distribution of keratan sulfate glycosaminoglycans
was studied, using an indirect immunoperoxidase
method, in embryonic chick hind limbs. Four separated
monoclonal antibodies, each antibody recognizing epi-
topes present in both keratan sulfate type I and type II,
were used. Each antibody varied in its ability to
recognize epitopes on these two forms of keratan
sulfate (Table 1). This suggests that these antibodies
may recognize subtle epitope differences within glycos-
aminoglycan chains.
All four antibodies identified what appeared, at low
magnification, to be discrete foci of immunostain in day
5-5 and day 6-5 limbs (not shown). At higher magnifi-
cation, these foci were found to correspond to joints
and articular surfaces of the knee (see below), tibiotar-
sal, and metatarsophalangeal joints (not shown).
Lesser, diminishing amounts of keratan sulfate were
detected in epiphyseal and diaphyseal regions of both
femurs and tibias.
Others have already described the distribution of
keratan sulfate in the metatarsophalangeal joint (Craig
et al. 1987a); therefore, this study has concentrated on
results obtained from the knee joint. The structure of
the anterior region of a knee joint obtained from a day
6-5 embryo is shown in Fig. 1. The joint capsule,
articular cartilages, femoral and tibial heads are ident-
ified. The joint cavity has not yet formed; consequently,
the femur and tibia are still connected by cells that will
subsequently degenerate and die to form the joint
space. This latter is termed the interzone region
(Holder, 1977).
All four anti-keratan sulfate monoclonal antibodies
identified high levels of keratan sulfate in the joint
region (Fig. 2A). Intense zones of immunostain were
confined to articular cartilages and to a band, which
apparently connected the femoral and tibial heads, that
extended along the apical margin of the joint capsule.
This band may represent either ligament or developing
patellar tissue (Fell & Canti, 1934). Both the interzone
region and the region immediately subjacent to the
immunostained apical band lacked detectable keratan
sulfate. Also, no keratan sulfate was detectable in the
posterior aspect of the joint capsule (not shown).
Lesser, but detectable, levels of keratan sulfate were
present in epiphyseal cartilages. This nonuniform distri-
bution of keratan sulfate did not reflect the distribution
of all glycosaminoglycans, since immunostaining using
anti-chondroitin sulfate antibodies 3B3 and 2B6 pro-
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Fig. 1. The anterior portion of a knee joint from a day 6-5
embryo is shown. The femoral (F) and tibial (T) heads are
covered by articular cartilage (a). These two bones are still
connected by cells forming the interzone region (z). Arrows
indicate the anterior margin of the joint capsule.
Hematoxylin and eosin, X115, bar = 35/an.
duced very different patterns (Fig. 2B,C). Chondroitin-
6 sulfate (3B3) was intensely detected in joint and
articular regions, including regions where there was no
detectable keratan sulfate (compare Fig. 2A and B). In
contrast, chondroitin-4/dermatan sulfates appeared to
be generally absent from these sites (Fig. 2C). These
results suggest that some chondroitin sulfate proteogly-
cans in the joint may be substituted with both chondroi-
tin and keratan sulfate glycosaminoglycans, while
others may be substituted with only chondroitin sul-
fates. It also indicates that a differential distribution of
chondroitin and keratan sulfates occurs at this early
stage of development.
The abrupt transition between articular and epiphy-
seal cartilages was due to the amount of extracellular
keratan sulfate. In contrast to the articular zone, only a
thin halo of pericellular keratan sulfate was seen
surrounding many epiphyseal chondrocytes (Fig. 3). In
the diaphyseal region, even this pericellular immuno-
stain was not detected by any of the anti-keratan sulfate
antibodies (bottom of Fig. 3 and Fig. 4). Based upon
studies of counterstained samples (not shown), keratan
sulfate epitopes were restricted to a single juxtanuclear
site. This was not evident in all cells, possibly due to the
fact that this is sectioned tissue and that some juxtanuc-
lear sites may have been out of the plane of section
(Fig. 4). Three out of four anti-keratan sulfate anti-
bodies identified this intracellular keratan sulfate (see
below). This pattern of keratan sulfate distribution
translated, at lower magnifications, to a gradient in
keratan sulfate content. As in the joint region, the
apparent lack of extracellular keratan sulfate in diaphy-
seal regions was not due to the lack of proteoglycans,
since anti-chondroitin sulfate antibodies readily
detected extracellular glycosaminoglycans in this zone
(Fig- 5).
The absence of extracellular keratan sulfate in the
diaphyseal region appeared to be age-related, since
extracellular keratan sulfate could be detected within
this region of bones obtained from older embryos. By
day 9-5, both pericellular and extracellular keratan
suffate were detected by all four anti-keratan sulfate
antibodies (Fig. 6). In fact, by day 11-5, keratan sulfate
was intensely detected in diaphyseal regions (Fig. 7). In
other words, the high content of diaphyseal keratan
7* B
Fig. 2. (A) Keratan sulfate (antibody 4A1) is intensely immunostained in articular cartilage (arrowheads) and in a band
extending along the apical margin of the joint capsule (arrows). Epiphyseal cartilages of femoral and tibial heads is less
intensely immunostained. No keratan sulfate is detected in the interzone (z) region. (B) Unlike keratan sulfate, chondroitin-
6 sulfate (antibody 3B3) is present throughout the joint capsule, including the interzone region. It is also readily detected in
articular and epiphyseal cartilages. (C) Chondroitin-4/dermatan sulfate (antibody 2B6) distribution is very different from
both keratan sulfate and chondroitin-6 sulfate. It is almost completely absent from the joint region and from articular
cartilages, but is detected in epiphyseal cartilages. x90, bar = 40/xm.
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Fig. 3. Extracellular keratan sulfate (antibody 4A1) is
readily detected in articular cartilage (a) from a day 6-5
femur. However, an abrupt transition occurs at the
articular-epiphyseal boundary. In the epiphyseal region (e),
keratan sulfate is restricted to a pericellular region around
most chondrocytes (arrowheads). No pericellular keratan
sulfate is detected around any chondrocyte (arrows) in the
proximal portion of the diaphysis (d). X380, bar= Yijim.
sulfate persisted in bones of older embryos, as did the
high content of keratan sulfate in articular cartilages
and joint tissues, such as the meniscus (Fig. 8). Thus,
the distribution of keratan sulfate appears to be both
spatially and age-related.
Differences in epitope expression were detected by
comparing the results of the four anti-keratan sulfate
monoclonal antibodies. In younger embryos, all four
monoclonals detected epitopes in joints, articular and
epiphyseal regions. However, there were distinct differ-
ences in keratan sulfate epitopes detected in middle
regions of bones. Antibody 4A1 provided the strongest
immunocytochemical detection of intracytoplasmic epi-
tope; while antibodies 2D3 and 5D4 both provided
intermediate detection; and, finally, antibody 1B4
barely detected epitope (Fig. 9). These results strongly
suggest that a differential expression of keratan sulfate
occurs at this site. Similarly, differences in keratan
sulfate epitope expression were noted in bones ob-
tained from older embryos. As shown in Fig. 10,
antibodies 2D3 and 5D4 differentially identified kera-
tan sulfate in femoral condyle from a day 18 embryo.
Both monoclonals detected cell-associated epitope, but
only antibody 2D3 detected extracellular epitope, par-
ticularly in articular cartilage. Thus, different forms of
Fig. 4. At higher magnifications no extracellular or
pericellular keratan sulfate can be detected in mid-
diaphyseal regions (same bone as shown in Fig. 3). Cell
surfaces of chondrocytes lack detectable pericellular
immunostain (arrowheads). However, intracellular keratan





Fig. 5. Extracellular and pericellular chondroitin sulfates
are present in the diaphyseal regions of bones from day 6-5
embryos. The distributions of different chondroitin sulfates
are similar except that (A) chondroitin-4/dermatan sulfate
(antibody 2B6) is detected in osteoid (arrows), but
(B) chondroitin-6 sulfate (antibody 3B3) is not detected
(arrow), x320, bar = 16/an.
keratan sulfate likely exist and can be discriminated
immunologically. Furthermore, their expression ap-
pears to be related to both the location of the chondro-
cyte producing the epitope and the developmental age
of that chondrocyte.
Fig. 6. Extracellular (arrows) and pericellular (arrowheads)
keratan sulfate (antibody 2D3) is detectable in the
diaphyseal regions of bones from day 9-5 embryos (note the
differences in the immunostaining pattern shown in this
bone compared with that shown in Fig. 4). x585,
bar =
Fig. 7. Extracellular keratan sulfate is readily detected in
the mid-diaphyseal region (arrows) of bones older than that
shown in Fig. 6 (antibody 5D4, day 11 embryo). x75,
bar = 53 jim.
Discussion
The most striking feature observed in developing hind
limbs of chick embryos was the high content of keratan
sulfate, as determined by imrnunocytochemical analy-
ses. Even more interestingly, keratan sulfate was not
uniformly distributed throughout cartilage, but was
concentrated within joints and developing articular
cartilage surfaces. In contrast, chondroitin/dermatan
sulfates were more widely distributed throughout all
regions of cartilage. The highest extracellular concen-
trations of keratan sulfate corresponded to regions that
Keratan sulfates in skeletal development 661
/
Fig. 8. Articular cartilages (arrows) and joint tissues of the
knee, such as the meniscus (m), continue to be intensely
immunostained by anti-keratan sulfate antibodies (antibody
2D3) in older (day 9-5) embryos. x95, bar = 42/m\.
also contained a high content of chondroitin-6 sulfate,
but low chondroitin-4/dermatan sulfate content. Taken
together, these observations indicate that metabolic
heterogeneity, in terms of glycosaminoglycan synthesis,
occurs, and that these different populations of cells are
highly organized into identifiable regions.
Similar conclusions, based upon data obtained from
biochemical studies of cartilages, have been reached by
others (De Luca et al. 1977; Garg et al. 1981; Pacifici et
al. 1981; Webber et al. 1987). The relative contents of
chondroitin and keratan sulfate were found to vary
according to location and to depth within cartilage
(Franzen et al. 1981; Zanetti et al. 1985; Williams et al.
1988). Vasan & Lash (1978) found that articular carti-
lage of embryonic chick tibias contained a higher
keratan sulfate content than did epiphyseal cartilage.
This was confirmed in this study; furthermore, the
present data indicate that equally high contents of
keratan sulfate were located in some of the noncartila-
ginous tissues of the developing joint.
In bones from younger embryos, a gradient in kera-
tan sulfate content was observed that, upon closer
inspection, proved to be related to the amount of
extracellular keratan sulfate. In bones from younger
embryos, extracellular keratan sulfate was detected in
articular and epiphyseal regions. Even between these
latter two zones remarkable differences in the amounts
of keratan sulfate were noted; considerably more extra-
cellular keratan sulfate was present in the articular
zone. In the zones containing flattened cells and hyper-
trophic cells, keratan sulfate was restricted to intracy-
toplasmic, juxtanuclear regions, presumably corre-
sponding to the Golgi apparatus, as has been previously
suggested (Vertel & Barkman, 1984). Vertel & Bark-
man (1984), in a study of cultured embryonic chick
chondrocytes, found that, while all of these cells pro-
duced extracellular chondroitin sulfate, only some pro-
duced detectable extracellular keratan sulfate. How-
ever, keratan sulfate could be detected in some of those
cells that did not display this glycosaminoglycan extra-
cellularly. From this they concluded that chondroitin
and keratan sulfate synthesis and secretion were inde-





Fig. 9. Sections obtained from diaphyseal region of the same day 6:5 tibia have been immunostained using antibodies 4A1
(A), 2D3 (B), and 1B4 (C) and have been presented for comparison. Note that there are significant differences in epitope
detection. Antibodies 4A1 and 2D3 (also antibody 5D4, not shown) detect epitope which is located intracellularly (see
Fig. 4). In contrast, antibody 1B4 fails to detect epitope in this region. X340, bars = 15 pra.
\
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Fig. 10. Sections of a day 18 femoral condyle have been
immunostained using antibodies 2D3 (A) and 5D4 (B).
Note that, in both figures, epiphyseal chondrocytes are
darkly immunostained, indicating the presence of keratan
sulfate closely associated with these cells. In contrast,
keratan sulfate within extracellular matrix, especially that
within articular cartilages (arrows), is identified by antibody
2D3 (A), but not by antibody 5D4 (B). x65, bars = 60/im.
pendently regulated. Zanetti etal. (1985), in a separate
study, reached similar conclusions. In intact bones, a
similar independent regulation also appears to exist,
but here, regulation seems to depend upon the location
of chondrocytes within the developing bone. These
results indicate that the differential ability of chondro-
cytes to store or to secrete keratan sulfate relates to
developmental age.
Substantial, age-related increases in keratan sulfate
content have been documented in both mammalian and
avian cartilages. This increase is accomplished by the
substitution of more, and longer, keratan sulfate chains
to chondroitin sulfate proteoglycans (De Luca et al.
19T7; Garg et al. 1981; Pacifici et al. 1981; Webber et al.
1988). In the chick embryo, increased keratan sulfate
was immunocytochemically detected by day 9-5. At that
time, extracellular keratan sulfate was noted in the
diaphyseal regions of both femurs and tibias. Extra-
cellular keratan sulfate persisted in all regions of
cartilage in older embryos. Thus, the present data
indicate that most chondrocytes are capable of syn-
thesizing keratan sulfate, as evidenced by its intracyto-
plasmic detection. However, the secretion of keratan
sulfate, and/or its extracellular metabolism, may be
independently regulated.
With the development of anti-keratan sulfate mono-
clonal antibodies has come the realization that keratan
sulfate is much more widely distributed than had
previously been expected (Funderburgh et al. 1987).
Recent immunocytochemical studies have identified
keratan sulfate in such noncartilaginous tissues as
tendons, ligaments, and other joint tissues (Craig et al.
1987a,6). In addition, the development of significant
numbers of different anti-keratan sulfate monoclonal
antibodies has revealed that considerable heterogeneity
exists within keratan sulfate chains, indicating that
keratan sulfate glycosaminoglycan structure is not
simply related to keratan sulfate type I or type II
(SundarRaj etal. 1986; Funderburgh etal. 1987, 1988).
At least some of this heterogeneity is likely related to
variations in sulfation patterns that occur within these
chains (Mehmet et al. 1986; Tang et al. 1986; Funder-
burgh et al. 1987). Direct evidence for differences in
keratan sulfate epitopes has been documented for
antibodies 5D4 and 1B4. Antibody 5D4 appears to
recognize a more highly sulfated epitope than does
antibody 1B4 (Mehmet et al. 1986). Others have also
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suggested that sulfation of keratan sulfate is an import-
ant factor in tissue and developmental distribution of
keratan sulfate (SundarRaj et al. 1986; Funderburgh et
al. 1988). The differential detection of keratan sulfate
by monoclonal antibodies in chick cartilage suggests
that the types of keratan sulfate are developmentally
related. Too little is yet known to make predictions
about the role that different forms of keratan sulfate
might have in influencing the structure of extracellular
matrices.
In conclusion, keratan sulfate glycosaminoglycans
are present in embryonic chick limbs at very early
stages. Their synthesis and distribution, like that of
chondroitin/dermatan sulfate glycosaminoglycans (Shi-
nomura et al. 1984), appears to be both spatially- and
age-related. Presumably, this differential keratan sul-
fate content has important influences on the structure
and function of extracellular matrices present in differ-
ent locations.
This work was supported by NIH grants CA40059, RR
05433, and AR32666.
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